Marjorie Taylor Greene bought BP PLC ADR (NYSE: BP)
Marjorie Taylor Greene (R-GA), a U.S. Representative, has disclosed 1 trade in BP PLC ADR (BP) since 2025, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Marjorie Taylor Greene bought $1,001 - $15,000 of BP PLC ADR (NYSE: BP) on May 5, 2025. Since that trade, BP is up +58.98% against the S&P 500 up +30.94%, an outperformance of +28.04%.
Data updated
Marjorie Taylor Greene's BP trades vs the price
BP is up +58.98% since Marjorie Taylor Greene bought on May 5, 2025, versus +30.94% for the S&P 500.
Performance since this trade
All Marjorie Taylor Greene BP trades
Marjorie Taylor Greene & BP trading FAQ
Is it legal for Marjorie Taylor Greene to trade BP PLC ADR (BP) stock?
Yes. Members of Congress are allowed to trade individual stocks, including BP PLC ADR (BP), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Marjorie Taylor Greene buy BP?
Marjorie Taylor Greene disclosed a purchase of $1,001 - $15,000 of BP PLC ADR (BP) on May 5, 2025, according to public STOCK Act filings.
How has BP performed since Marjorie Taylor Greene's trade?
Since Marjorie Taylor Greene bought BP on May 5, 2025, the stock is up +58.98%, versus +30.94% for the S&P 500 over the same period, an outperformance of +28.04%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BP trades?
Quantellect tracks every disclosed congressional trade in BP PLC ADR (BP) on the BP PLC ADR congressional trading page, which aggregates filings across all members of Congress.
Marjorie Taylor Greene's BP tradesAll congressional filings for BP PLC ADRMarjorie Taylor Greene's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.